56 related articles for article (PubMed ID: 37299516)
1. Natural Products and Health.
Bartkowiak-Wieczorek J; Mądry E
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337699
[TBL] [Abstract][Full Text] [Related]
2. Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone.
Akbar S; Subhan F; Akbar A; Habib F; Shahbaz N; Ahmad A; Wadood A; Salman S
Nutrients; 2023 May; 15(11):. PubMed ID: 37299516
[TBL] [Abstract][Full Text] [Related]
3. Cassia artemisiodes attenuates nociceptive and diabetes-induced neuropathic pain modalities apropos antioxidant and anti-inflammatory mechanisms.
Ullah R; Badshah W; Ali G; Ullah A; Khan SU; Ahmad N; Shahid M; Naveed M; Ullah S; Bangash SA; Althobaiti YS
Biomed Pharmacother; 2022 May; 149():112834. PubMed ID: 35339108
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic evaluation of a novel cyclohexenone derivative's functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach.
Khan J; Ali G; Rashid U; Khan R; Jan MS; Ullah R; Ahmad S; Abbasi SW; Khan Khalil AA; Sewell RE
Eur J Pharmacol; 2021 Jul; 902():174091. PubMed ID: 33865830
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 2-Hydroxyflavanone in Rodent Models of Pain and Inflammation: Involvement of Opioidergic and GABAergic Anti-Nociceptive Mechanisms.
Khan FA; Ali G; Rahman K; Khan Y; Ayaz M; Mosa OF; Nawaz A; Hassan SSU; Bungau S
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080199
[TBL] [Abstract][Full Text] [Related]
6. The 7-Hydroxyflavone attenuates chemotherapy-induced neuropathic pain by targeting inflammatory pathway.
Ullah R; Ali G; Rasheed A; Subhan F; Khan A; Ahsan Halim S; Al-Harrasi A
Int Immunopharmacol; 2022 Jun; 107():108674. PubMed ID: 35276461
[TBL] [Abstract][Full Text] [Related]
7. 6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain.
Akbar S; Subhan F; Karim N; Shahid M; Ahmad N; Ali G; Mahmood W; Fawad K
Biomed Pharmacother; 2016 Dec; 84():962-971. PubMed ID: 27764759
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
Sloan G; Selvarajah D; Tesfaye S
Nat Rev Endocrinol; 2021 Jul; 17(7):400-420. PubMed ID: 34050323
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and peripheral neuropathy.
Kazamel M; Stino AM; Smith AG
Muscle Nerve; 2021 Mar; 63(3):285-293. PubMed ID: 33098165
[TBL] [Abstract][Full Text] [Related]
10. Molecular Modelling, Synthesis and Evaluation of Flavone and Flavanone Scaffolds as Anti-inflammatory Agents.
Kiruthiga N; Alagumuthu M; Selvinthanuja C; Srinivasan K; Sivakumar T
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):20-38. PubMed ID: 31899683
[TBL] [Abstract][Full Text] [Related]
11. Zona Incerta: An Integrative Node for Global Behavioral Modulation.
Wang X; Chou XL; Zhang LI; Tao HW
Trends Neurosci; 2020 Feb; 43(2):82-87. PubMed ID: 31864676
[TBL] [Abstract][Full Text] [Related]
12. The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: The innate pain-relieving system.
Bán EG; Brassai A; Vizi ES
Brain Res Bull; 2020 Feb; 155():129-136. PubMed ID: 31816407
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for Reducing Neuropathic Pain.
Kuffler DP
Mol Neurobiol; 2020 Jan; 57(1):67-87. PubMed ID: 31813127
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
